Zacks Research Brokers Increase Earnings Estimates for THC

Tenet Healthcare Co. (NYSE:THC) – Research analysts at Zacks Research increased their Q2 2025 EPS estimates for shares of Tenet Healthcare in a research note issued on Wednesday, February 26th. Zacks Research analyst R. Department now anticipates that the company will earn $2.68 per share for the quarter, up from their previous estimate of $2.66. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $3.36 EPS and FY2025 earnings at $11.84 EPS.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

THC has been the topic of a number of other reports. KeyCorp dropped their price objective on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Truist Financial dropped their price objective on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective on the stock. in a research report on Friday, November 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $177.00 target price on shares of Tenet Healthcare in a research report on Thursday, February 13th. Finally, The Goldman Sachs Group downgraded shares of Tenet Healthcare from a “buy” rating to a “neutral” rating and dropped their target price for the company from $196.00 to $140.00 in a research report on Monday, December 16th. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $163.88.

Tenet Healthcare Trading Down 1.4 %

Shares of NYSE:THC opened at $122.77 on Monday. Tenet Healthcare has a 52 week low of $90.03 and a 52 week high of $171.20. The company’s 50 day moving average is $132.79 and its two-hundred day moving average is $146.53. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The company has a market cap of $11.68 billion, a PE ratio of 3.81, a P/E/G ratio of 1.02 and a beta of 2.05.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. FMR LLC lifted its stake in shares of Tenet Healthcare by 88.0% in the 3rd quarter. FMR LLC now owns 7,700,693 shares of the company’s stock worth $1,279,855,000 after acquiring an additional 3,604,161 shares during the period. Geode Capital Management LLC lifted its stake in shares of Tenet Healthcare by 3.5% in the 4th quarter. Geode Capital Management LLC now owns 2,116,121 shares of the company’s stock worth $268,591,000 after acquiring an additional 71,454 shares during the period. Norges Bank acquired a new stake in shares of Tenet Healthcare in the 4th quarter worth $190,819,000. Dimensional Fund Advisors LP lifted its stake in shares of Tenet Healthcare by 22.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,493,532 shares of the company’s stock worth $188,524,000 after acquiring an additional 272,906 shares during the period. Finally, AQR Capital Management LLC lifted its stake in shares of Tenet Healthcare by 20.8% in the 4th quarter. AQR Capital Management LLC now owns 872,117 shares of the company’s stock worth $110,087,000 after acquiring an additional 150,361 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.